This fourth module of the Santé Cannabis Prescriber Training Program details treatment plan recommendations for anxiety and depression in five sections.
Describes symptom expression in anxiety and depression and provides realistic therapeutic goals of a medical cannabis treatment.
Presents medical guidelines for Quebec physicians, details pharmaceutical and non-pharmaceutical conventional treatments for anxiety and depression and discusses the physician’s role.
Provides a general overview of the endocannabinoid system implication in depression and anxiety and discusses scientific evidence supporting medical cannabis use for anxious and depressive symptoms.
Provides medical cannabis treatment recommendations about pharmaceutical cannabinoids, administration route, cannabinoid selection and special considerations to keep in mind.
Presents a case study 1 and summarizes learnings from this and prior modules.